SSKN - STRATA Skin Sciences holder closes new fund
Accelmed Partners, a private equity investor of Strata Skin Sciences (SSKN), has closed its oversubscribed second fund, Accelmed Fund II, LP with the $400M of capital commitments exceeding the original target of $300M.Fund II’s precursor, Accelmed Fund I, LP that closed in 2016 with $130M in capital commitments made investments in Strata which is now trading ~17.5% higher in the pre-market.Early this month, STRATA announced an expansion for its direct distribution agreement with Wuhan Miracle Laser Systems (Miracle) targeting recurring revenue as well as direct capital from sales in China.
For further details see:
STRATA Skin Sciences holder closes new fund